Megan started using ketamine at 14. By 22, she needed nappies. For the last two years she has been in agony and unable to stand straight, according to an article reporting on a rise in young people entering rehab for ketamine addiction. The story ties her physical collapse directly to her ketamine use.
The case is being held up as an example of what prolonged ketamine use does to the bladder and urinary tract — damage that builds quietly and then becomes hard to live with. The article also notes a broader increase in young people seeking treatment.
What Megan's timeline shows
The numbers in Megan's case are blunt. Eight years between first use and needing nappies. Two years of constant pain and a posture she can't correct. The article doesn't say where she lives, what treatment she's had, or how much she was using. It doesn't need to for the point to land: ketamine harm isn't a short-term hangover.
📊 Market Data Snapshot
That timeline matters because it sits behind the rise in rehab admissions the article describes. Young people showing up for treatment now may have started using years earlier. The damage often surfaces well after the habit began.
Why rehab numbers are climbing
The article frames the increase in young people going to rehab as a trend, not a one-off. It doesn't break the numbers down by region, age band, or service type. What it does is put a face on the trend through Megan's case — a user who started as a teenager and is now dealing with consequences that affect how she stands, sits, and sleeps.
Ketamine's reputation as a party drug hasn't caught up with what long-term users describe. The article's focus on bladder damage and incontinence is a reminder that the drug's medical risks are physical and lasting, not just psychological.
The gap in the story
There's no jurisdiction attached to the rehab data. No country, no health service, no date range for the admissions increase. That absence makes it hard to compare the trend to official figures or to know whether this is a local spike or a wider pattern.
It also means the article leans on Megan's case to carry the weight of the trend. One detailed example, clearly told, can do that. But it leaves open questions about how many people are affected and how quickly the numbers are moving.
What's clear from the facts is the sequence: early use, years of hidden damage, then a point where the body forces the issue. Megan's two years of pain and her inability to stand straight are the visible end of that sequence. The rehab admissions suggest more people are arriving at the same place.
The next concrete step would be treatment data that shows where these admissions are coming from and whether the rise is concentrated among younger users. Until then, Megan's case is the clearest picture available of what the trend looks like at the individual level.
